2020
DOI: 10.21577/0100-4042.20170581
|View full text |Cite
|
Sign up to set email alerts
|

Novas Tecnologias Para O Tratamento Da Tuberculose: O Que as Patentes Nos Dizem

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 0 publications
0
1
0
1
Order By: Relevance
“…Despite advancements in therapeutic protocols, there remains a risk that the disease could become untreatable for some individuals. Thus, developing new strategies to address the escalating resistance to current medications is essential [28]. Exploratory data analysis was employed to investigate patterns and associations between TB and conditions such as diabetes, alcoholism, drug use, HIV, and smoking.…”
Section: Resultsmentioning
confidence: 99%
“…Despite advancements in therapeutic protocols, there remains a risk that the disease could become untreatable for some individuals. Thus, developing new strategies to address the escalating resistance to current medications is essential [28]. Exploratory data analysis was employed to investigate patterns and associations between TB and conditions such as diabetes, alcoholism, drug use, HIV, and smoking.…”
Section: Resultsmentioning
confidence: 99%
“…Segundo Neto et al (2020) os protocolos de tratamento abrangem os esquemas terapêuticos para os diferentes perfis de resistência da doença, sendo estes: resistência a Rifampicina (TBRR); multirresistência (TBMDR), quando há resistência a pelo menos Rifampicina e Isoniazida; e resistência extensiva (TBXDR), quando há resistência à Rifampicina e Isoniazida acrescida de resistência às fluoroquinolonas e aos medicamentos de segunda linha, ou seja, aqueles já usados por resistência anterior ou por intolerância.…”
Section: Resultsunclassified